NL7503310A - Verbindingen met antidepressieve werking. - Google Patents

Verbindingen met antidepressieve werking.

Info

Publication number
NL7503310A
NL7503310A NL7503310A NL7503310A NL7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A
Authority
NL
Netherlands
Prior art keywords
connections
antidepressive action
antidepressive
action
Prior art date
Application number
NL7503310A
Other languages
English (en)
Dutch (nl)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Priority to NL7503310A priority Critical patent/NL7503310A/xx
Priority to ZA761434A priority patent/ZA761434B/xx
Priority to DE19762610886 priority patent/DE2610886A1/de
Priority to IL49238A priority patent/IL49238A/xx
Priority to GB10703/76A priority patent/GB1535226A/en
Priority to SE7603341A priority patent/SE410312B/xx
Priority to CH334576A priority patent/CH626057A5/de
Priority to FI760699A priority patent/FI61875C/fi
Priority to DK115976A priority patent/DK144942C/da
Priority to AT195476A priority patent/AT340895B/de
Priority to HU76PI00000513A priority patent/HU171030B/hu
Priority to IT21320/76A priority patent/IT1063064B/it
Priority to PL1976199556A priority patent/PL100052B1/pl
Priority to PL1976199557A priority patent/PL101951B1/pl
Priority to PL1976188006A priority patent/PL100614B1/pl
Priority to CA248,102A priority patent/CA1076142A/en
Priority to GR50333A priority patent/GR60052B/el
Priority to DD7600191893A priority patent/DD128332A5/xx
Priority to SU762335241A priority patent/SU635867A3/ru
Priority to ES446192A priority patent/ES446192A1/es
Priority to BE165316A priority patent/BE839744A/xx
Priority to YU714/76A priority patent/YU39345B/xx
Priority to AU12147/76A priority patent/AU505358B2/en
Priority to IE567/76A priority patent/IE43768B1/en
Priority to US05/668,461 priority patent/US4085225A/en
Priority to FR7608019A priority patent/FR2304336A1/fr
Priority to JP51029394A priority patent/JPS6026776B2/ja
Priority to AR262650A priority patent/AR211011A1/es
Publication of NL7503310A publication Critical patent/NL7503310A/xx
Priority to AR265801A priority patent/AR211153A1/es
Priority to AT41377A priority patent/AT342568B/de
Priority to AT317277A priority patent/AT342574B/de
Priority to SU772503814A priority patent/SU645559A3/ru
Priority to SU772503815A priority patent/SU620206A3/ru
Priority to CH153981A priority patent/CH629184A5/de
Priority to CH154181A priority patent/CH629761A5/de
Priority to CH154081A priority patent/CH629477A5/de
Priority to MX9203723A priority patent/MX9203723A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7503310A 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking. NL7503310A (nl)

Priority Applications (37)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.
ZA761434A ZA761434B (en) 1975-03-20 1976-03-09 Compounds having anti-depressive activity
DE19762610886 DE2610886A1 (de) 1975-03-20 1976-03-16 Verbindungen mit antidepressiver wirkung
DD7600191893A DD128332A5 (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von verbindungen mit antidepressiver wirkung
GB10703/76A GB1535226A (en) 1975-03-20 1976-03-17 Oximes
SE7603341A SE410312B (sv) 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar
CH334576A CH626057A5 (en:Method) 1975-03-20 1976-03-17
FI760699A FI61875C (fi) 1975-03-20 1976-03-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara trifluormetylfenon-0-(2-aminoetyl)-oximer
DK115976A DK144942C (da) 1975-03-20 1976-03-17 Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
AT195476A AT340895B (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
HU76PI00000513A HU171030B (hu) 1975-03-20 1976-03-17 Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju
IT21320/76A IT1063064B (it) 1975-03-20 1976-03-17 Composti aventi attivita antidepressiva a base di eteri ossimici derivati da fenilchetoni
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu
CA248,102A CA1076142A (en) 1975-03-20 1976-03-17 Substituted butyrophenone o-(2-aminoethyl) oxime derivatives
GR50333A GR60052B (en) 1975-03-20 1976-03-17 Preparation process of anti-depressive compounds
IL49238A IL49238A (en) 1975-03-20 1976-03-17 O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
SU762335241A SU635867A3 (ru) 1975-03-20 1976-03-17 Способ получени производных оксима или их солей
IE567/76A IE43768B1 (en) 1975-03-20 1976-03-18 Oximes
ES446192A ES446192A1 (es) 1975-03-20 1976-03-18 Un metodo de preparacion de nuevos compuestos de oxima-eter.
BE165316A BE839744A (fr) 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation
YU714/76A YU39345B (en) 1975-03-20 1976-03-18 Process for preparing new oxime ether compounds
AU12147/76A AU505358B2 (en) 1975-03-20 1976-03-18 Alkylphenone-0-(aminoethyl)oxime derivatives
US05/668,461 US4085225A (en) 1975-03-20 1976-03-19 Oxime ethers having anti-depressive activity
FR7608019A FR2304336A1 (fr) 1975-03-20 1976-03-19 Composes a effet anti-depressif et procedes de preparation
JP51029394A JPS6026776B2 (ja) 1975-03-20 1976-03-19 新規オキシムエーテル化合物
AR262650A AR211011A1 (es) 1975-03-20 1976-03-22 Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c3-c4)-sustuitido-ptrifluormetilfenilcetoxin
AR265801A AR211153A1 (es) 1975-03-20 1976-12-10 Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.
AT41377A AT342568B (de) 1975-03-20 1977-01-24 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT317277A AT342574B (de) 1975-03-20 1977-05-04 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
SU772503814A SU645559A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
SU772503815A SU620206A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
CH153981A CH629184A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154181A CH629761A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154081A CH629477A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
MX9203723A MX9203723A (es) 1975-03-20 1992-06-29 Compuestos que tienen actividad anti-depresiva.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
NL7503310A true NL7503310A (nl) 1976-09-22

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Country Status (27)

Country Link
US (1) US4085225A (en:Method)
JP (1) JPS6026776B2 (en:Method)
AR (2) AR211011A1 (en:Method)
AT (1) AT340895B (en:Method)
AU (1) AU505358B2 (en:Method)
BE (1) BE839744A (en:Method)
CA (1) CA1076142A (en:Method)
CH (4) CH626057A5 (en:Method)
DD (1) DD128332A5 (en:Method)
DE (1) DE2610886A1 (en:Method)
DK (1) DK144942C (en:Method)
ES (1) ES446192A1 (en:Method)
FI (1) FI61875C (en:Method)
FR (1) FR2304336A1 (en:Method)
GB (1) GB1535226A (en:Method)
GR (1) GR60052B (en:Method)
HU (1) HU171030B (en:Method)
IE (1) IE43768B1 (en:Method)
IL (1) IL49238A (en:Method)
IT (1) IT1063064B (en:Method)
MX (1) MX9203723A (en:Method)
NL (1) NL7503310A (en:Method)
PL (3) PL101951B1 (en:Method)
SE (1) SE410312B (en:Method)
SU (3) SU635867A3 (en:Method)
YU (1) YU39345B (en:Method)
ZA (1) ZA761434B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU6776196A (en) * 1995-08-16 1997-03-12 Eli Lilly And Company Potentiation of serotonin response
IN182588B (en:Method) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (en:Method) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
WO2001080845A2 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
CA2462903C (en) * 2001-10-12 2011-09-20 Serenix Pharmaceuticals, Llc Beta-lactamyl vasopressin v1a antagonists
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
ATE473967T1 (de) * 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2601709C (en) 2005-03-22 2017-02-14 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids
JP2008538573A (ja) 2005-04-22 2008-10-30 ワイス ベンゾフラニルアルカナミン誘導体およびその５−ｈｔ２ｃアゴニストとしての使用
AR056979A1 (es) * 2005-04-22 2007-11-07 Wyeth Corp Derivados de dihidrobenzofuranos y usos de los mismos
US20060252825A1 (en) * 2005-04-22 2006-11-09 Wyeth Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
US7402687B2 (en) 2005-04-22 2008-07-22 Wyeth Dihydrobenzofuran derivatives and uses thereof
CA2614289A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
PL1910346T3 (pl) * 2005-07-19 2019-09-30 Azevan Pharmaceuticals, Inc. Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
NZ564789A (en) * 2005-07-22 2010-07-30 Myriad Genetics Inc High drug load formulations and dosage forms
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007231011A1 (en) * 2006-03-24 2007-10-04 Wyeth New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
PT2491038T (pt) 2009-10-23 2016-07-14 Janssen Pharmaceutica Nv Octahidropirrolo[3,4-c]pirrolos disubstituídos como modeladores de recetores de orexina
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ 眼疾患を治療する化合物および方法
ES2858499T3 (es) 2010-07-01 2021-09-30 Azevan Pharmaceuticals Inc Compuestos para su uso en el tratamiento de trastorno explosivo intermitente
BR112013023810A2 (pt) 2011-03-17 2016-12-13 Lupin Ltd composições farmacêuticas de liberação controlada de inibidores seletivos da recaptação de serotonina
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
WO2014178064A2 (en) * 2013-04-03 2014-11-06 Zcl Chemicals Limited "an improved process for the preparation of fluvoxamine maleate"
CN106456578B (zh) 2014-02-07 2020-02-18 匈牙利科学院大学及其他机构附属研究所 Sigma-1受体激动剂化合物的用途
SG10202001065SA (en) 2014-03-28 2020-04-29 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
MY197558A (en) 2016-03-10 2023-06-23 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
US12239125B2 (en) 2016-11-24 2025-03-04 SigmaDrugs Kutató Korlátolt Felelsség Társaság Compositions for organ preservation
EP3681871A4 (en) 2017-09-15 2021-05-26 Azevan Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BRAIN DAMAGE
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Also Published As

Publication number Publication date
CH629477A5 (de) 1982-04-30
MX9203723A (es) 1992-07-01
DK115976A (da) 1976-09-21
FI61875C (fi) 1982-10-11
PL100052B1 (pl) 1978-08-31
SU620206A3 (ru) 1978-08-15
CH629184A5 (de) 1982-04-15
IE43768L (en) 1976-09-20
SU635867A3 (ru) 1978-11-30
CH629761A5 (de) 1982-05-14
JPS51125345A (en) 1976-11-01
SE410312B (sv) 1979-10-08
AU505358B2 (en) 1979-11-15
ES446192A1 (es) 1977-10-01
IL49238A0 (en) 1976-05-31
HU171030B (hu) 1977-10-28
GB1535226A (en) 1978-12-13
ATA195476A (de) 1977-05-15
SE7603341L (sv) 1976-09-21
DE2610886C2 (en:Method) 1987-09-24
YU71476A (en) 1982-10-31
YU39345B (en) 1984-10-31
DD128332A5 (de) 1977-11-09
PL100614B1 (pl) 1978-10-31
SU645559A3 (ru) 1979-01-30
FI760699A7 (en:Method) 1976-09-21
DE2610886A1 (de) 1976-10-07
PL101951B1 (pl) 1979-02-28
JPS6026776B2 (ja) 1985-06-25
IE43768B1 (en) 1981-05-20
AR211153A1 (es) 1977-10-31
IT1063064B (it) 1985-02-11
GR60052B (en) 1978-04-04
BE839744A (fr) 1976-09-20
FR2304336B1 (en:Method) 1979-09-28
AT340895B (de) 1978-01-10
CA1076142A (en) 1980-04-22
AU1214776A (en) 1977-09-22
DK144942B (da) 1982-07-12
ZA761434B (en) 1977-10-26
US4085225A (en) 1978-04-18
IL49238A (en) 1978-08-31
AR211011A1 (es) 1977-10-14
FI61875B (fi) 1982-06-30
DK144942C (da) 1982-12-06
FR2304336A1 (fr) 1976-10-15
CH626057A5 (en:Method) 1981-10-30

Similar Documents

Publication Publication Date Title
NL7503310A (nl) Verbindingen met antidepressieve werking.
NO143239C (no) Pumpeanordning.
NO145331C (no) Barberhoevelpatron.
NL7611944A (nl) 1,2,3-triazolen met kalmerende werking.
NO141839C (no) Enkeltpunkts-fortoeyningsboeye.
OA05436A (fr) PRRresse.
NO142980C (no) Magnetiseringslednings-gjennomfoeringsbolt.
NL7503312A (nl) Verbindingen met antidepressieve werking.
NL7504369A (nl) Terpenofenolen met farmacologische werking.
NL7504370A (nl) Terpenofenoxyalkylaminen met farmacologische werking.
NL7503311A (nl) Verbindingen met antidepressieve werking.
NL7503309A (nl) Verbindingen met antidepressieve werking.
BE849303A (fr) Tranducteur.
NL7600039A (nl) 5-fenyl-2-furamidoximen.
NL7610639A (nl) Schouw.
NL7608586A (nl) Hoogoven-tuyere.
NL7609127A (nl) Oscillograaf.
NL7503308A (nl) Verbindingen met antidepressieve werking.
NL7503307A (nl) Antidepressieve verbindingen.
DK135101B (da) Slaglemølle.
NL7610437A (nl) Verbindingen met analgetische werking.
ES212889Y (es) Cohete-senal.
DK151559C (da) Kartonaeske.
ES209316Y (es) Muneco mecanico.
NL7610438A (nl) Nieuwe groep verbindingen met analgetische werking.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: DUPHAR INTERNATIONAL RESEARCH B.V.

BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed